A randomized phase II trial of bevacizumab vs. bevacizumab and erlotinib as first-line consolidation after carboplatin, paclitaxel, and bevacizumab in newly diagnosed patients with mullerian tumors
Titel:
A randomized phase II trial of bevacizumab vs. bevacizumab and erlotinib as first-line consolidation after carboplatin, paclitaxel, and bevacizumab in newly diagnosed patients with mullerian tumors
Auteur:
Campos, Susana Matulonis, Ursula Berlin, Suzanne Horowitz, Neil Liu, Joyce Krasner, Carolyn Hang, Lee Zarwan, Corrine Barry, William Colella, Tina Whalen, Christen Shoni, Melina Lundquist, Christine Birrer, Michael J. Penson, Richard